The researchers will use Sapientia to analyze samples from 1,000 fetuses as part of efforts to develop an exome-based assay for non-invasive prenatal testing.
MetaSUB researchers will sample high-traffic areas across subway systems, buses, and parks in cities such as New York, San, Francisco, Buenos Aires, Sydney, and London.
Called CanPathPro, the research consortium aims to combine omics data and systems biology tools into a single commercial platform for testing cancer hypotheses.
The portal offers access to genotype, phenotype, and clinical data related to type 2 diabetes as well as computational tools for querying the information.
Within the consortium community healthcare systems can contribute and access each other's data on cancer patients' molecular profiles and treatment outcomes.
The White House Office of Science and Technology Policy is collaborating with federal agencies and private companies to study microbiomes in different ecosystems.
Researchers from EBI, Georgetown, and others are mapping protein annotations to the human reference genome to it more easily accessible.
As part of the effort, Virus.X also aims to craft new sequencing approaches, bioinformatics tools, and targeted gene products.
The Ontario Institute for Cancer Research will work with prostate cancer data while Dana Farber Cancer Institute's pilot has yet to be decided.
The group will offer free access to omic and clinical data from the project and develop software to help clinicians use the models in patient care.
A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.
A new analysis finds some cancers receive more nonprofit dollars than others.
An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.
In Science this week: comparative analysis of sex differences in mammal gene expression, and more.